MAA Laboratories careers

Problems with Existing Drugs
Existing drug products formulated from small molecules with low solubility and bioavailability inherently cause one or more of the following patient issues: non-optimal dose, low therapeutic efficiency, higher side/adverse effects, higher toxicity, higher food effects, and patient variability. It is well documented that ~40% of existing drugs have low solubility and poor bioavailability.

MAA Solution
MAA creates better drug products by using our proprietary NanoContTM technology to reformulate drugs on the market. Reformulation of drug products using MAAs technology can bring new revenues for pharma companies. MAAs technology can also be used for small molecules in development to successfully bring new drug products to market.